Alberta · CCAA

Affidavit No.5 of Gord Boersma

Affidavit · 24 September 2026

AI summary

A plain-English summary drawn only from this filing: what it is, why it matters, and the parties, amounts and dates it turns on.

What we verified from this filing1 verified

unsecured creditorsnote: Claim by the CRO for unpaid fees and expenses (amounts owing to him personally and via his operating company), not a trade or lender claim; no priority or charge is stated on these pages. Components: (1) $24,542.72 fees payable to GAB while CRO (pre-Feb 6 Order), paid to SRI; (2) $1,899.53 expense reimbursement outstanding from Sirona Pharma Inc.; (3) $114,513.98 trailing work fees post Feb 6 per Monitor's Sixth Report; (4) $59,062.50 trailing success fee re: Amended Interim Financing advance (Feb 6 Order); (5) $149,625.00 trailing SISP bonus fee; (6) $100,000.00 estimated legal fees (an estimate, not an invoiced amount). Detailed tracker (p.5) shows total SRI billing of $373,536.48, GAB earned $270,771.41, payments to GAB $131,714.72, due to GAB $139,056.69 before expenses, bonus fees and estimated legal fees. · page: 4 · as of: 2026-09-24 · basis: Affiant's own claim: 'Summary Schedule of Fees and expenses owed to Grand Arc Bend Inc.' as at September 24, 2026; stated as 'Estimated payable to GAB' and 'Entitlement per Contract' · amount: 449643.72 · debtor: Sirona Pharma Inc. (and the CCAA Companies) · creditor: Gord Boersma / Grand Arc Bend Inc. (court-appointed CRO; fees and expenses) · currency: CAD